HFrEF-话题@MedSci

#HFrEF#

17篇内容 | 960人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2155766, encodeId=e1e32155e66ba, content=<a href='/topic/show?id=b8f710393629' target=_blank style='color:#2F92EE;'>#芪苈强心胶囊#</a>可改善<a href='/topic/show?id=3d858e829d' target=_blank style='color:#2F92EE;'>#HFrEF#</a>患者预后！, objectTitle=ESC 2023：芪苈强心胶囊可改善HFrEF患者预后！, objectType=article, longId=789391, objectId=2adde8939174, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20230830/b6c0d7635be7420ead4c6427a9094226.jpg, objectUrl=/article/show_article.do?id=2adde8939174, replyNumber=0, likeNumber=41, createdTime=2023-09-02, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=2adde8939174, moduleTitle=ESC 2023：芪苈强心胶囊可改善HFrEF患者预后！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2adde8939174)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=1396188, encodeId=804c13961884e, content=<a href='/topic/show?id=3d858e829d' target=_blank style='color:#2F92EE;'>#HFrEF#</a>, objectTitle=西地那非并没有改善HFrEF和PH患者的症状、生活质量或运动能力, objectType=article, longId=727597, objectId=fe3be27597ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe3be27597ab, replyNumber=0, likeNumber=52, createdTime=2022-05-24, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe3be27597ab, moduleTitle=西地那非并没有改善HFrEF和PH患者的症状、生活质量或运动能力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe3be27597ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1396187, encodeId=32c4139618ed8, content=<a href='/topic/show?id=3d858e829d' target=_blank style='color:#2F92EE;'>#HFrEF#</a>, objectTitle=JAMA子刊：新药沙库巴曲缬沙坦治疗晚期HFrEF患者有效性不足, objectType=article, longId=294141, objectId=4aff29414108, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4aff29414108, replyNumber=0, likeNumber=38, createdTime=2022-01-19, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4aff29414108, moduleTitle=JAMA子刊：新药沙库巴曲缬沙坦治疗晚期HFrEF患者有效性不足, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4aff29414108)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1396186, encodeId=ce4f13961861e, content=<a href='/topic/show?id=3d858e829d' target=_blank style='color:#2F92EE;'>#HFrEF#</a>, objectTitle=JAHA：抑郁症状、心脏结构和功能与HFpEF和HFrEF风险的关系, objectType=article, longId=220936, objectId=89322209363b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89322209363b, replyNumber=0, likeNumber=36, createdTime=2021-11-25, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89322209363b, moduleTitle=JAHA：抑郁症状、心脏结构和功能与HFpEF和HFrEF风险的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89322209363b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1396185, encodeId=be8d1396185c4, content=<a href='/topic/show?id=3d858e829d' target=_blank style='color:#2F92EE;'>#HFrEF#</a>, objectTitle=JAMA：住院前后护理质量干预措施对HFrEF心力衰竭患者临床结果的影响, objectType=article, longId=215196, objectId=b0f721519671, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0f721519671, replyNumber=0, likeNumber=46, createdTime=2021-08-04, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0f721519671, moduleTitle=JAMA：住院前后护理质量干预措施对HFrEF心力衰竭患者临床结果的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0f721519671)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1396184, encodeId=891d1396184d4, content=<a href='/topic/show?id=3d858e829d' target=_blank style='color:#2F92EE;'>#HFrEF#</a>, objectTitle=Circulation：恩格列净可逆转合并2型糖尿病的HFrEF患者的心室重构！, objectType=article, longId=207019, objectId=deb920e01943, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=deb920e01943, replyNumber=0, likeNumber=38, createdTime=2021-02-11, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=deb920e01943, moduleTitle=Circulation：恩格列净可逆转合并2型糖尿病的HFrEF患者的心室重构！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=deb920e01943)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1396183, encodeId=63361396183d4, content=<a href='/topic/show?id=3d858e829d' target=_blank style='color:#2F92EE;'>#HFrEF#</a>, objectTitle=Circulation：达格列净治疗对HFrEF患者肾功能和预后的效益, objectType=article, longId=206283, objectId=2c802062839a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c802062839a, replyNumber=0, likeNumber=48, createdTime=2021-01-28, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c802062839a, moduleTitle=Circulation：达格列净治疗对HFrEF患者肾功能和预后的效益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c802062839a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1396182, encodeId=2ca51396182b4, content=<a href='/topic/show?id=3d858e829d' target=_blank style='color:#2F92EE;'>#HFrEF#</a>, objectTitle=急性左心衰、右心衰、慢性HFrEF，正性肌力药物怎么用？这篇文章都讲清楚了！, objectType=article, longId=176197, objectId=17941e619708, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17941e619708, replyNumber=0, likeNumber=40, createdTime=2019-07-27, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17941e619708, moduleTitle=急性左心衰、右心衰、慢性HFrEF，正性肌力药物怎么用？这篇文章都讲清楚了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17941e619708)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1396181, encodeId=061d139618160, content=<a href='/topic/show?id=3d858e829d' target=_blank style='color:#2F92EE;'>#HFrEF#</a>, objectTitle=Circulation：卡格列净降低HFpEF和HFrEF的心衰事件风险, objectType=article, longId=174676, objectId=a6591e467638, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6591e467638, replyNumber=0, likeNumber=33, createdTime=2019-07-03, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6591e467638, moduleTitle=Circulation：卡格列净降低HFpEF和HFrEF的心衰事件风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6591e467638)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1396180, encodeId=1e5013961802c, content=<a href='/topic/show?id=3d858e829d' target=_blank style='color:#2F92EE;'>#HFrEF#</a>, objectTitle=Eur Heart J：80岁以上的HFrEF患者 RAS抑制剂的生存获益不逊于年轻人, objectType=article, longId=158947, objectId=3c1215894e57, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c1215894e57, replyNumber=0, likeNumber=28, createdTime=2019-01-28, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c1215894e57, moduleTitle=Eur Heart J：80岁以上的HFrEF患者 RAS抑制剂的生存获益不逊于年轻人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c1215894e57)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1396179, encodeId=c70813961e924, content=<a href='/topic/show?id=3d858e829d' target=_blank style='color:#2F92EE;'>#HFrEF#</a>, objectTitle=JACC:HFrEF患者药物治疗：实践为何与指南相去甚远？, objectType=article, longId=147826, objectId=f78b14e826e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f78b14e826e3, replyNumber=0, likeNumber=32, createdTime=2018-09-01, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f78b14e826e3, moduleTitle=JACC:HFrEF患者药物治疗：实践为何与指南相去甚远？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f78b14e826e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1396178, encodeId=d4ca13961e804, content=<a href='/topic/show?id=3d858e829d' target=_blank style='color:#2F92EE;'>#HFrEF#</a>, objectTitle=JAHA：HFpEF与HFREF患者住院期间肾功能恶化的预测和预后价值！, objectType=article, longId=132339, objectId=5ad213233993, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ad213233993, replyNumber=0, likeNumber=34, createdTime=2018-03-15, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ad213233993, moduleTitle=JAHA：HFpEF与HFREF患者住院期间肾功能恶化的预测和预后价值！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ad213233993)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1396177, encodeId=226f13961e767, content=<a href='/topic/show?id=3d858e829d' target=_blank style='color:#2F92EE;'>#HFrEF#</a>, objectTitle=JAMA：HFrEF高危患者：钠尿肽指导的治疗优于常规治疗？, objectType=article, longId=116089, objectId=44811160896e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44811160896e, replyNumber=0, likeNumber=32, createdTime=2017-10-15, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44811160896e, moduleTitle=JAMA：HFrEF高危患者：钠尿肽指导的治疗优于常规治疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44811160896e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1396176, encodeId=e2ba13961e669, content=<a href='/topic/show?id=3d858e829d' target=_blank style='color:#2F92EE;'>#HFrEF#</a>, objectTitle=Eur J Heart Fail：HFrEF患者：不同β-受体阻滞剂与不同剂量获益是否不同？, objectType=article, longId=111184, objectId=2f94111184a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f94111184a9, replyNumber=0, likeNumber=35, createdTime=2017-08-30, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f94111184a9, moduleTitle=Eur J Heart Fail：HFrEF患者：不同β-受体阻滞剂与不同剂量获益是否不同？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f94111184a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1396175, encodeId=5bd913961e5f4, content=<a href='/topic/show?id=3d858e829d' target=_blank style='color:#2F92EE;'>#HFrEF#</a>, objectTitle=Circ-Heart Fail：HFREF和HFPEF患者RAAS抑制剂、WRF和预后之间的关系？, objectType=article, longId=89242, objectId=f0b18924290, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0b18924290, replyNumber=0, likeNumber=42, createdTime=2017-02-19, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0b18924290, moduleTitle=Circ-Heart Fail：HFREF和HFPEF患者RAAS抑制剂、WRF和预后之间的关系？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0b18924290)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1396174, encodeId=2e2313961e490, content=<a href='/topic/show?id=3d858e829d' target=_blank style='color:#2F92EE;'>#HFrEF#</a>, objectTitle=Lancet：Ixmyelocel-T细胞疗法或将是HFrEF患者的福音, objectType=article, longId=66121, objectId=528e66121d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=528e66121d4, replyNumber=0, likeNumber=40, createdTime=2016-04-07, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=528e66121d4, moduleTitle=Lancet：Ixmyelocel-T细胞疗法或将是HFrEF患者的福音, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=528e66121d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1396173, encodeId=674613961e3bd, content=<a href='/topic/show?id=3d858e829d' target=_blank style='color:#2F92EE;'>#HFrEF#</a>, objectTitle=HFpEF与HFrEF：伪命题还是真命题？, objectType=article, longId=3017, objectId=c9eb301eec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c9eb301eec, replyNumber=0, likeNumber=32, createdTime=2011-08-24, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c9eb301eec, moduleTitle=HFpEF与HFrEF：伪命题还是真命题？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c9eb301eec)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

2020-05-29

(审核中...)

前往app查看评论内容

#芪苈强心胶囊#可改善#HFrEF#患者预后！

ESC 2023：芪苈强心胶囊可改善HFrEF患者预后！

2023-09-02发表于上海

智者为医08 (审核中...)

前往app查看评论内容

#HFrEF#

西地那非并没有改善HFrEF和PH患者的症状、生活质量或运动能力

2022-05-24

智者为医08 (审核中...)

前往app查看评论内容

#HFrEF#

JAMA子刊：新药沙库巴曲缬沙坦治疗晚期HFrEF患者有效性不足

2022-01-19

智者为医08 (审核中...)

前往app查看评论内容

#HFrEF#

JAHA：抑郁症状、心脏结构和功能与HFpEF和HFrEF风险的关系

2021-11-25

智者为医08 (审核中...)

前往app查看评论内容

#HFrEF#

JAMA：住院前后护理质量干预措施对HFrEF心力衰竭患者临床结果的影响

2021-08-04

智者为医08 (审核中...)

前往app查看评论内容

#HFrEF#

Circulation：恩格列净可逆转合并2型糖尿病的HFrEF患者的心室重构！

2021-02-11

智者为医08 (审核中...)

前往app查看评论内容

#HFrEF#

Circulation：达格列净治疗对HFrEF患者肾功能和预后的效益

2021-01-28

智者为医08 (审核中...)

前往app查看评论内容

#HFrEF#

急性左心衰、右心衰、慢性HFrEF，正性肌力药物怎么用？这篇文章都讲清楚了！

2019-07-27

智者为医08 (审核中...)

前往app查看评论内容

#HFrEF#

Circulation：卡格列净降低HFpEF和HFrEF的心衰事件风险

2019-07-03

智者为医08 (审核中...)

前往app查看评论内容

#HFrEF#

Eur Heart J：80岁以上的HFrEF患者 RAS抑制剂的生存获益不逊于年轻人

2019-01-28

智者为医08 (审核中...)

前往app查看评论内容

#HFrEF#

JACC:HFrEF患者药物治疗：实践为何与指南相去甚远？

2018-09-01

智者为医08 (审核中...)

前往app查看评论内容

#HFrEF#

JAHA：HFpEF与HFREF患者住院期间肾功能恶化的预测和预后价值！

2018-03-15

智者为医08 (审核中...)

前往app查看评论内容

#HFrEF#

JAMA：HFrEF高危患者：钠尿肽指导的治疗优于常规治疗？

2017-10-15

智者为医08 (审核中...)

前往app查看评论内容

#HFrEF#

Eur J Heart Fail：HFrEF患者：不同β-受体阻滞剂与不同剂量获益是否不同？

2017-08-30

智者为医08 (审核中...)

前往app查看评论内容

#HFrEF#

Circ-Heart Fail：HFREF和HFPEF患者RAAS抑制剂、WRF和预后之间的关系？

2017-02-19

智者为医08 (审核中...)

前往app查看评论内容

#HFrEF#

Lancet：Ixmyelocel-T细胞疗法或将是HFrEF患者的福音

2016-04-07

智者为医08 (审核中...)

前往app查看评论内容

#HFrEF#

HFpEF与HFrEF：伪命题还是真命题？

2011-08-24

科室
- - 订阅+
  - 更多科室
工具
服务